IL37 and myocardial ischemia: By using a myocardial ischemia/reperfusion injury model, Wu et al. found that exogenous IL-37 reduced infarct size, decreased cardiac troponin T levels, and improved cardiac function via suppressing the production of proinflammatory cytokines and chemokines and the infiltration of leukocyte [13].